Technetium Tc-99m tilmanocept Recruiting Phase 1 Trials for Kaposi s Sarcoma (KS) / Human Immunodeficiency Virus (HIV) / Human Immunodeficiency Virus (HIV) Infections Diagnostic

IndicationsStatusPurposePhase
RecruitingDiagnostic1
clinicaltrials.gov IdentifierTitleDrugs
NCT03157167An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)